Chantal Raymond | 27/11/2023
The hemophilia community has been waiting for gene therapy for years; many hoped it would be a cure. Quantitative and qualitative results from late stages of clinical trials for...
Chantal Raymond | 17/11/2023
For almost 25 years, the CHS has played a key role in raising awareness about bleeding disorders that affect women. In 2012, to ensure the continuity and effectiveness of...
David Page | 27/10/2023
Ottawa, October 26, 2023 – Health Canada has authorized Hemgenix (etranacogene dezaparvovec), gene therapy for the treatment of hemophilia B. Hemgenix is indicated for the treatment of adults with...
CHS/SCH | 19/07/2023
The Canadian bleeding disorder treatment centres participed in a rigorous self-assessment of their services from November 2022 to February 2023. IT IS NOW TIME TO HEAR FROM PATIENTS AND...